| Peginterferon alfa-2a |
EU/1/02/221/007 |
Pegasys, Solution for injection, 180 mcg/0,5 ml, -, Pack: 1 pre-filled syringe + 1 injection needle |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
259.48 |
51.9 |
311.38 |
4% |
10 |
269.48 |
53.9 |
323.38 |
16% |
25 |
294.48 |
58.9 |
353.38 |
|
НСР-8434/07.03.2016 |
22.03.2016 |
Активен |
3302 |
| Peginterferon alfa-2a |
EU/1/02/ 221/005 |
Pegasys, Solution for injection, 135 mсg/0,5 ml, -, Pack: 1 pre-filled syringe + 1 injection needle |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
225.27 |
45.05 |
270.32 |
4% |
9.01 |
234.28 |
46.86 |
281.14 |
16% |
25 |
259.28 |
51.86 |
311.14 |
|
НСР-6425/12.06.2015. |
26.06.2015 |
Активен |
3252 |
| Peginterferon alfa-2a |
EU/1/02/221/014 |
Pegasys, Solution for injection, 180 mcg/0,5 ml, -, Pack: 1 pre-filled pen |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
259.5 |
51.9 |
311.4 |
4% |
10 |
269.5 |
53.9 |
323.4 |
16% |
25 |
294.5 |
58.9 |
353.4 |
|
НСР-5935/01.04.2015. |
16.04.2015 |
Активен |
3771 |
| Peginterferon alfa-2a |
EU/1/02/221/011 |
Pegasys, Solution for injection, 135 mсg/0,5 ml, -, Pack: 1 pre-filled pen |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
225.27 |
45.05 |
270.32 |
4% |
9.01 |
234.28 |
46.86 |
281.14 |
16% |
25 |
259.28 |
51.86 |
311.14 |
|
НСР-5934/01.04.2015. |
16.04.2015 |
Активен |
3770 |
| Peginterferon alfa-2a |
EU/1/02/221/007 |
Pegasys, Solution for injection, 180, mсg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
259.5 |
51.9 |
311.4 |
4% |
10 |
269.5 |
53.9 |
323.4 |
16% |
25 |
294.5 |
58.9 |
353.4 |
|
НСР-6542/24.06.2015 |
10.07.2015 |
Неактивен |
3302 |
| Peginterferon alfa-2a |
EU/1/02/221/007 |
Pegasys, Solution for injection, 180, mсg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
288.31 |
57.66 |
345.97 |
4% |
10 |
298.31 |
59.66 |
357.97 |
16% |
25 |
323.31 |
64.66 |
387.97 |
|
НСР-4864/17.10.2014 |
03.11.2014 |
Неактивен |
3302 |
| Peginterferon alfa-2a |
EU/1/02/221/005 |
Pegasys, Solution for injection, 135, mсg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
245.34 |
49.07 |
294.41 |
4% |
9.81 |
255.15 |
51.03 |
306.18 |
16% |
25 |
280.15 |
56.03 |
336.18 |
|
НСР-4813/ 13.10.2014 |
27.10.2014 |
Неактивен |
3252 |
| Peginterferon alfa-2a |
EU/1/02/221/005 |
Pegasys, Solution for injection, 135, mсg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
250.31 |
50.06 |
300.37 |
4% |
10 |
260.31 |
52.06 |
312.37 |
16% |
25 |
285.31 |
57.06 |
342.37 |
|
НСР-2314/13.01.2014 |
14.02.2014 |
Неактивен |
3252 |
| Peginterferon alfa-2a |
EU/1/02/221/007 |
Pegasys, Solution for injection, 180, mсg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
288.33 |
57.67 |
346 |
4% |
10 |
298.33 |
59.67 |
358 |
16% |
25 |
323.33 |
64.67 |
388 |
|
НСР-972/12.08.2013 |
29.08.2013 |
Неактивен |
3302 |
| Peginterferon alfa-2a |
EU/1/02/221/011 |
Pegasys, Solution for injection, 135, mсg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
250.31 |
50.06 |
300.37 |
4% |
10 |
260.31 |
52.06 |
312.37 |
16% |
25 |
285.31 |
57.06 |
342.37 |
|
НСР-438/09.07.2013 |
30.07.2013 |
Неактивен |
3770 |
| Peginterferon alfa-2a |
EU/1/02/221/014 |
Pegasys, Solution for injection, 180, mсg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
288.33 |
57.67 |
346 |
4% |
10 |
298.33 |
59.67 |
358 |
16% |
25 |
323.33 |
64.67 |
388 |
|
НСР-437/09.07.2013 |
30.07.2013 |
Неактивен |
3771 |
| Peginterferon alfa-2a |
EU/1/02/221/005 |
Pegasys, Solution for injection, 135, mсg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
257.04 |
51.41 |
308.45 |
4% |
10 |
267.04 |
53.41 |
320.45 |
16% |
25 |
292.04 |
58.41 |
350.45 |
|
КЦРР-2734/20.03.2013 |
18.04.2013 |
Неактивен |
3252 |
| Peginterferon alfa-2a |
EU/1/02/221/014 |
Pegasys, Solution for injection, 180, mсg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
320.36 |
64.07 |
384.43 |
4% |
10 |
330.36 |
66.07 |
396.43 |
16% |
25 |
355.36 |
71.07 |
426.43 |
|
КЦРР-960/16.07.2012 |
02.08.2012 |
Неактивен |
3771 |
| Peginterferon alfa-2a |
EU/1/02/221/011 |
Pegasys, Solution for injection, 135, mсg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
278.12 |
55.62 |
333.74 |
4% |
10 |
288.12 |
57.62 |
345.74 |
16% |
25 |
313.12 |
62.62 |
375.74 |
|
КЦРР-960/16.07.2012 |
02.08.2012 |
Неактивен |
3770 |
| Peginterferon alfa-2a |
EU/1/02/221/007 |
Pegasys, Solution for injection, 180, mсg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
311.43 |
62.29 |
373.72 |
4% |
10 |
321.43 |
64.29 |
385.72 |
16% |
25 |
346.43 |
69.29 |
415.72 |
|
КЦРР-628/18.05.2012 |
11.06.2012 |
Неактивен |
3302 |
| Peginterferon alfa-2a |
EU/1/02/221/001 |
Pegasys, Solution for injection, 135, mсg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Diagnostics GmbH - Germany |
292.63 |
58.53 |
351.16 |
4% |
10 |
302.63 |
60.53 |
363.16 |
16% |
25 |
327.63 |
65.53 |
393.16 |
|
КЦ-1878/25.10.2010 |
|
Неактивен |
3252 |
| Peginterferon alfa-2a |
EU/1/02/221/007 |
Pegasys, Solution for injection, 180, mсg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG - Germany |
368.97 |
73.79 |
442.76 |
6% |
15 |
383.97 |
76.79 |
460.76 |
18% |
30 |
413.97 |
82.79 |
496.76 |
|
КЦ-529/13.02.2009 |
02.03.2009 |
Неактивен |
3302 |
| peginterferon alfa-2b |
EU/1/00/131/047 |
Pegintron, Powder and solvent for solution for injection, 150, mсg, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP Labo N.V., Белгия |
414.13 |
82.83 |
496.96 |
4% |
10 |
424.13 |
84.83 |
508.96 |
16% |
25 |
449.13 |
89.83 |
538.96 |
|
НСР-5063/18.11.2014 |
08.12.2014 |
Неактивен |
3366 |
| peginterferon alfa-2b |
EU/1/00/ 131/035 |
Pegintron, Powder and solvent for solution for injection, 80, mсg, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
221.34 |
44.27 |
265.61 |
4% |
8.85 |
230.19 |
46.04 |
276.23 |
16% |
25 |
255.19 |
51.04 |
306.23 |
|
НСР-4300/05.08.2014 |
20.08.2014 |
Неактивен |
3695 |
| peginterferon alfa-2b |
EU/1/00/ 131/043 |
Pegintron, Powder and solvent for solution for injection, 120, mсg, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
331.94 |
66.39 |
398.33 |
4% |
10 |
341.94 |
68.39 |
410.33 |
16% |
25 |
366.94 |
73.39 |
440.33 |
|
НСР-4302/05.08.2014 |
20.08.2014 |
Неактивен |
3694 |
| peginterferon alfa-2b |
EU/1/00/ 131/039 |
Pegintron, Powder and solvent for solution for injection, 100, mсg, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
274.38 |
54.88 |
329.26 |
4% |
10 |
284.38 |
56.88 |
341.26 |
16% |
25 |
309.38 |
61.88 |
371.26 |
|
НСР-1977/06.12.2013 |
24.12.2013 |
Неактивен |
3140 |
| peginterferon alfa-2b |
EU/1/00/ 131/035 |
Pegintron, Powder and solvent for solution for injection, 80, mсg, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
222.32 |
44.46 |
266.78 |
4% |
8.89 |
231.21 |
46.24 |
277.45 |
16% |
25 |
256.21 |
51.24 |
307.45 |
|
НСР-1977/06.12.2013 |
24.12.2013 |
Неактивен |
3695 |
| peginterferon alfa-2b |
EU/1/00/ 131/043 |
Pegintron, Powder and solvent for solution for injection, 120, mсg, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
333.27 |
66.65 |
399.92 |
4% |
10 |
343.27 |
68.65 |
411.92 |
16% |
25 |
368.27 |
73.65 |
441.92 |
|
НСР-1977/06.12.2013 |
24.12.2013 |
Неактивен |
3694 |
| peginterferon alfa-2b |
EU/1/00/ 131/039 |
Pegintron, Powder and solvent for solution for injection, 100, mсg, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
283.52 |
56.7 |
340.22 |
4% |
10 |
293.52 |
58.7 |
352.22 |
16% |
25 |
318.52 |
63.7 |
382.22 |
|
КЦРР-2284/20.02.2013 |
18.03.2013 |
Неактивен |
3140 |
| peginterferon alfa-2b |
EU/1/00/ 131/035 |
Pegintron, Powder and solvent for solution for injection, 80, mсg, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
SP (Brinny) Company, Ireland |
228.75 |
45.75 |
274.5 |
4% |
9.15 |
237.9 |
47.58 |
285.48 |
16% |
25 |
262.9 |
52.58 |
315.48 |
|
КЦРР-2285/20.02.2013 |
18.03.2013 |
Неактивен |
3695 |